Screening embryos for breast cancer

April 26, 2007

A slippery slope?

Until recently, the screening – called pre-implantation genetic diagnosis (PGD) – was approved only for genes that always cause diseases when inherited, such as in cystic fibrosis . . .

. . . Last May, the watchdog ruled it acceptable for doctors to screen embryos for genes such as BRCA1, which raise the risk of cancer in adulthood by 60-80%.

However, it still has to approve each application on a “case by case” basis – something these couples are still waiting for.

Critics say if the HFEA does give the go ahead it is a continued journey down a slippery slope to “designer babies”. There is concern that in the future embryos could be screened for non-lethal and even trivial conditions.

Also, the procedure means that affected embryos are created and then destroyed.



Related posts:

  1. "The great majority of women in the United States should not be getting MRI scans for breast cancer screening"
  2. CNN dismisses the ACP on breast cancer screening
  3. Templated charting
  4. Why health reformers should be worried about the breast cancer screening backlash
  5. MRI for breast cancer screening
  6. Will patients accept the new, evidence-based, breast cancer screening guidelines?
  7. Breast cancer screening: Orac’s take


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: Abortion ship

Next post: Hospitals: "Even a dose of last century’s computer technology could go a long way toward cutting waste"

Site Meter